Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Bahl Raghav Nath VWE Vintage Wine Estates, Inc. Common Stock 13G/A 1.8% 2y
MILTON C. AULT, III GPUS Hyperscale Data, Inc. 13D/A 85.72% 2y
Carlyle Group Inc. QDEL QuidelOrtho Corp 13D/A 15.4% 2y
Madison Avenue Partners, LP ONL Orion Properties Inc. 13G/A — 2y
Joshua Harris APO Apollo Global Management, Inc. 13D/A 6% 2y
Abdiel Qualified Master Fund, LP APPN Appian Corp 13D/A 18.6% 2y
MAZ Partners LP KLNG Koil Energy Solutions, Inc. 13D/A 5.2% 2y
Townsend AC, LLC BEEM Beam Global 13D/A 5.3% 2y
Insight Venture Partners X, L.P. NCNO nCino, Inc. 13D/A 17% 2y
INCYTE CORP MRUS Merus N.V. Common Shares 13G/A 1.5% 2y
Brehm Sean Michael FCCN SPECTRAL CAPITAL Corp 13D 41.91% 2y
Value Base Ltd. VLN Valens Semiconductor Ltd. 13D 18.51% 2y
Pacific Investment Management Company LLC VEL Velocity Financial, Inc. 13D/A 36.5% 2y
Hein Park Capital Management LP DBD DIEBOLD NIXDORF, Inc 13D/A 7.66% 2y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 71.04% 2y
Todd G. Schwartz OPFI OppFi Inc. 13D/A 77.2% 2y
Bandera Partners LLC IVFH Innovative Food Holdings Inc 13D/A 9.9% 2y
Saba Capital Management, L.P. NFJ Virtus Dividend, Interest & Premium Strategy Fund 13D/A 6.41% 2y
Gangjiang Li RTCJF Baijiayun Group Ltd 13D/A 28.2% 2y
White Hat Capital Partners LP LUNA Luna Innovations Incorporated 13D/A 9.99% 2y
Temasek Holdings (Private) Ltd CHRS Coherus Oncology, Inc. 13G/A 4.8% 2y
Brio Capital Master Fund Ltd. BDRX Biodexa Pharmaceuticals Plc 13G 9.83% 2y
Radoff Bradley Louis RMCF Rocky Mountain Chocolate Factory, Inc. 13D/A 9.5% 2y
4338618 Canada Inc. DOO BRP Inc. 13G/A 37.87% 2y
Barry J. Renbaum FMFG Farmers & Merchants Bancshares, Inc. 13D/A 9.9% 2y
CPC Pain & Wellness SPV, LLC XWEL XWELL, Inc. 13D/A 9.42% 2y
Atlas Investissement SAS TIGO Millicom International Cellular SA 13D/A 29.18% 2y
Davidson Kempner Capital Management LP AOMR Angel Oak Mortgage REIT, Inc. 13D/A 29.56% 2y
Andretti Sponsor LLC ZPTA Zapata Quantum, Inc. 13G/A 0% 2y
Ludmila Smolyansky LWAY Lifeway Foods, Inc. 13D/A 21.6% 2y
Iliad Research & Trading, L.P. JAGX Jaguar Health, Inc. 13G/A 9.13% 2y
Pacific Investment Management Company LLC VEL Velocity Financial, Inc. 13D/A 36.5% 2y
Denver J. Smith IVFH Innovative Food Holdings Inc 13D/A 8.7% 2y
M3 Funds, LLC CPBI Central Plains Bancshares, Inc. 13G 4.58% 2y
TANG CAPITAL MANAGEMENT, LLC HLVX HilleVax, Inc. Common Stock 13G 9.5% 2y
Lytton, Laurence W. TELA TELA Bio, Inc. 13G 5.4% 2y
TANG CAPITAL MANAGEMENT, LLC AGRX Agile Therapeutics, Inc 13G 6.2% 2y
Portolan Capital Management, LLC ORN Orion Group Holdings Inc 13G 5.5% 2y
Schulke Ryan FLNT Fluent, Inc. 13D/A 21.14% 2y
GLAZER CAPITAL, LLC SLCA U.S. SILICA HOLDINGS, INC. 13G 4.47% 2y
SONG, Hong Fang CGON CG Oncology, Inc. 13G 8.3% 2y
Mithaq Capital SPC BUR Burford Capital Ltd 13G/A 4.8% 2y
Greenhaven Road Investment Management, L.P. BNED Barnes & Noble Education, Inc. 13D/A 0% 2y
Redmile Group, LLC AUGX Augmedix, Inc. Common Stock 13D/A 40.5% 2y
Maurice J Duca APPF Appfolio Inc 13D/A 23.4% 2y
Liang Meng HOLI Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island) 13D/A 13.7% 2y
Newlinks Technology Limited NAAS NaaS Technology Inc. 13D/A 55.5% 2y
South Dakota Investment Council VTOL Bristow Group Inc. 13D/A 14.2% 2y
Senvest Management, LLC SATX SatixFy Communications Ltd. 13G 5% 2y
Saba Capital Management, L.P. ECF Ellsworth Growth & Income Fund Ltd 13D/A 9.03% 2y